Nasdaq Biotechnology Ishares ETF (IBB)
$156.93 0.22 (0.14%)
19:21 EST IBB Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 13.65B
PE Ratio -
Volume (Avg. Vol.) 4.56M
Day's Range 154.13 - 159.17
52-Week Range 92.15 - 174.04
Dividend & Yield 0.31 (0.20%)
IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News
- From InvestorPlace
- From the Web
Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.
Regardless of lockdowns or otherwise, these biotech stocks are positioned to rally strongly in the weeks and months ahead
This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.
Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.
Consensus is that the experts will find a vaccine to Covid-19 soon, so the biotech stocks have rallied hard. Buying them now carries risk.
Look for biotech stocks as a group to gain more than 20% this year … with the best, most innovative firms more than doubling.
By Ian Cooper
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
By Ian Cooper
Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
Our research and analysis have identified another name in biotech stocks with big potential in 2020.
By Ken Trester
This morning, I'm recommending a bullish call option on Aimmune Therapeutics, Inc. (NASDAQ:AIMT), the biopharmaceutical company.
Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.
Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.
From Talk Markets